AI assistant
Sending…
Larimar Therapeutics, Inc. — Director's Dealing 2015
Mar 3, 2015
33359_dirs_2015-03-03_ec0157f6-f876-4c0a-9591-f534d0979773.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2015-02-27
Reporting Person: Secor Alicia (Chief Commercial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-27 | Stock Option (Right to Buy) | $38.65 | A | 60000 | Acquired | 2025-02-27 | Common Stock (60000) | Direct |
Footnotes
F1: 25% of this option vests on February 27, 2016, and the remainder vests in equal monthly installments thereafter over 36 months.
More from Larimar Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Earnings Release
2026
Mar 19
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2